quinazolines has been researched along with zm323881 in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (31.25) | 29.6817 |
2010's | 11 (68.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bates, DO; Harper, SJ; Hennequin, LF; Kendrew, J; Pocock, TM; Wedge, SR; Whittles, CE | 1 |
Endo, A; Fukuhara, S; Masuda, M; Mochizuki, N; Ohmori, T | 1 |
Bates, DO; Harper, SJ; Neal, CR; Salmon, AH | 1 |
Ablonczy, Z; Crosson, CE | 1 |
Bodor, C; Dinya, E; Fazekas, A; Gyorfi, A; Gyurkovics, M; Iványi, I; Kónya, M; Lohinai, Z; Rosivall, L; Süveges, I; Székely, AD | 1 |
Cross, MJ; Fernig, DG; Uniewicz, KA | 1 |
Bates, DO; Bills, VL; Harper, SJ; Jeffery, B; Neal, CR; Overton, TG; Salmon, AH; Soothill, PW | 1 |
Cicha, I; Daniel, WG; Garlichs, CD; Urschel, K | 1 |
Bodor, C; Dinya, E; Győrfi, A; Gyurkovics, M; Lohinai, Z; Rosivall, L; Székely, AD | 1 |
Dinya, E; Fazekas, A; Gyorfi, A; Gyurkovics, M; Lohinai, Z; Rosivall, L; Székely, DA | 1 |
Guo, T; Li, L; Li, RJ; Pan, JH; Peng, YZ; Wang, Y; Yang, P; Zheng, K | 1 |
Ambudkar, SV; Chen, ZS; Liu, L; Shukla, S; Wang, YJ; Xu, H; Yang, DH; Zhang, D; Zhang, GN; Zhang, XY; Zhang, YK | 1 |
Boyun, S; Hongyi, H; Jiang, L; Jianye, Y; Ping, T; Shiying, W; Wanjun, Z | 1 |
Deissler, HL; Lang, GE; Lang, GK | 1 |
Bang, E; Deyama, S; Duman, RS; Dutheil, S; Dwyer, JM; Gerhard, DM; Kato, T; Li, XY; Picciotto, MR; Taylor, SR; Wohleb, ES | 1 |
Chu, YX; Cui, WQ; Du, LX; Hu, XM; Mao-Ying, QL; Mi, WL; Wang, YQ; Yang, W | 1 |
16 other study(ies) available for quinazolines and zm323881
Article | Year |
---|---|
ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity.
Topics: Animals; Capillary Permeability; Cell Division; Endothelium, Vascular; Enzyme Inhibitors; Lung; Microcirculation; Phosphorylation; Proteins; Quinazolines; Ranidae; Receptor Protein-Tyrosine Kinases; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2002 |
Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
Topics: Animals; Aorta; Cell Membrane; Cell Movement; Crk-Associated Substrate Protein; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Mice; NIH 3T3 Cells; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Retinoblastoma-Like Protein p130; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli.
Topics: Animals; Dose-Response Relationship, Drug; Glomerular Filtration Rate; In Vitro Techniques; Kidney Glomerulus; Male; Permeability; Quinazolines; Rats; Rats, Wistar; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Water | 2006 |
VEGF modulation of retinal pigment epithelium resistance.
Topics: Animals; Cell Line; Cell Membrane Permeability; Cells, Cultured; Dose-Response Relationship, Drug; Electric Impedance; Humans; Indoles; Pigment Epithelium of Eye; Pyrroles; Quinazolines; Retina; Sus scrofa; Tight Junctions; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Venodilatory effect of vascular endothelial growth factor on rat gingiva.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gingiva; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinazolines; Random Allocation; Rats; Rats, Wistar; Regional Blood Flow; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasodilator Agents; Venules | 2009 |
Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis.
Topics: Animals; Cell Movement; Coculture Techniques; Endothelial Cells; Extracellular Space; Fibroblasts; Gene Knockdown Techniques; Humans; Neovascularization, Physiologic; Neuropilin-1; Peptide Fragments; Protein Multimerization; Protein Structure, Quaternary; Quinazolines; Rats; Recombinant Proteins; Solubility; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Impaired vascular permeability regulation caused by the VEGF₁₆₅b splice variant in pre-eclampsia.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Assay; Capillary Permeability; Female; Humans; Membrane Proteins; Pre-Eclampsia; Pregnancy; Quinazolines; Ranidae; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2011 |
VEGFR2 signalling contributes to increased endothelial susceptibility to TNF-α under chronic non-uniform shear stress.
Topics: Active Transport, Cell Nucleus; Blotting, Western; Cell Adhesion; Cells, Cultured; Chromones; Coculture Techniques; Dose-Response Relationship, Drug; E-Selectin; Fluorescent Antibody Technique; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Mechanotransduction, Cellular; Monocytes; Morpholines; NF-kappa B; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; RNA Interference; src-Family Kinases; Stress, Mechanical; Transfection; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Microvascular regulatory role and increased expression of vascular endothelial growth factor receptor type 2 in experimental gingivitis.
Topics: Animals; Capillary Permeability; Endothelium, Vascular; Gingiva; Gingivitis; Male; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Pericytes; Quinazolines; Random Allocation; Rats; Rats, Wistar; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasoconstrictor Agents; Vasodilator Agents; Venules | 2013 |
[Investigation of the venodilatory effect of vascular endothelial growth factor (VEGF) in rat gingiva].
Topics: Animals; Capillary Permeability; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gingiva; Immunohistochemistry; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinazolines; Rats; Rats, Wistar; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vasodilation; Venules | 2013 |
Shock wave treatment enhances endothelial proliferation via autocrine vascular endothelial growth factor.
Topics: Autocrine Communication; Cell Proliferation; Cell Survival; Flavonoids; Gene Expression Regulation; High-Energy Shock Waves; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase 3; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Ultrasonic Therapy; Vascular Endothelial Growth Factor A | 2015 |
Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzimidazoles; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; HEK293 Cells; Humans; Mitoxantrone; Molecular Dynamics Simulation; Neoplasm Proteins; Quinazolines; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
The Different Effects of VEGFA121 and VEGFA165 on Regulating Angiogenesis Depend on Phosphorylation Sites of VEGFR2.
Topics: Anilides; Animals; Colitis, Ulcerative; Colon; Intestinal Mucosa; Neovascularization, Pathologic; Phosphorylation; Protein Isoforms; Pyridines; Quinazolines; Rats; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165.
Topics: Animals; Antibodies; Cattle; Cell Line, Transformed; Cell Membrane Permeability; Claudin-1; Claudin-5; Endothelial Cells; Gene Expression Regulation; Humans; Protein Kinase C; Protein Kinase Inhibitors; Quinazolines; Recombinant Proteins; Retina; Signal Transduction; Tight Junctions; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine.
Topics: Animals; Antibodies, Neutralizing; Behavior, Animal; Excitatory Amino Acid Antagonists; Gene Knockdown Techniques; Gene Knockout Techniques; In Vitro Techniques; Ketamine; Mice; Neurons; Prefrontal Cortex; Quinazolines; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Vascular Endothelial Growth Factor A Signaling Promotes Spinal Central Sensitization and Pain-related Behaviors in Female Rats with Bone Cancer.
Topics: Animals; Bone Neoplasms; Cancer Pain; Female; Injections, Spinal; Pain Measurement; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2019 |